RecruitingPhase 2Other

Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT)

Sponsored by University of Cincinnati

NCT ID
NCT05337618
Target Enrollment
72 participants
Start Date
2022-12-16
Est. Completion
2027-03-20

About This Study

This study is a randomized Phase 2 trial to determine the feasibility of real-time electrocorticographic monitoring of spreading depolarizations (SD) to guide implementation of a tier-based protocol of intensive care therapies, aimed at SD suppression, for the management of patients who have undergone acute operative treatment of severe traumatic brain injury.

Conditions Studied

Traumatic Brain Injury

Interventions

  • Full-band Electrocorticography
  • Treatment Algorithm

Eligibility

Age:18 Years - 80 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

(1) clinical indication for emergency craniotomy with dural opening to treat acute TBI within 72 hr post-trauma

Exclusion Criteria:

1. persistent bilateral non-reactive pupils or other evidence of non-survivable injury,
2. decompressive craniectomy to treat refractory ICP subsequent to diffuse injury, (3) co-enrollment in another therapeutic TBI trial, and

(4) pregnancy

Study Locations (1)

University of Cincinnati
Cincinnati, Ohio, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Jed A Hartings, PhD
CONTACT
513-295-2370jed.hartings@uc.edu
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source